Shalby releases Q1 FY27 earnings call transcript with management commentary
Shalby Limited disclosed its Q1 FY27 earnings call transcript on August 19, 2026. The filing details consolidated revenue of ₹338.6 crore and PAT of ₹10.5 crore. Management emphasized improved hospital occupancy rates and the first-time EBITDA break-even at the Gurgaon unit, signaling operational stabilization across key segments.
*this image is generated using AI for illustrative purposes only.
Shalby Limited has released the transcript of its earnings conference call for the first quarter of fiscal year 2027 (Q1 FY27). The call took place on August 13, 2026, and the transcript was filed with stock exchanges on August 19, 2026.
The company issued the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document references the company's intimation letter dated July 29, 2026, and Regulation 46(2).
Call Details
The earnings call was conducted on August 13, 2026, hosted by Elara Securities. Senior management, including Chairman and Managing Director Dr. Vikram Shah, Group CFO Amit Kumar, and Chief Operating Officer Dr. Nishita Shukla, participated in the session to discuss the unaudited financial results for Q1 FY27.
During the call, management reported that consolidated revenues stood at ₹338.6 crore, an 11.6% year-on-year increase from ₹303.4 crore in Q1 FY26. Consolidated EBITDA improved slightly to ₹49 crore from ₹48.5 crore, while consolidated PAT rose to ₹10.5 crore from ₹7.7 crore in the corresponding quarter last year.
Key operational highlights discussed included:
- Standalone hospital revenue of ₹259 crore, up approximately 7% year-on-year.
- Hospital occupancy rate reached 51% (excluding Shalby International), up from 54% previously, with occupied beds increasing to 701.
- Shalby International (Gurgaon unit) achieved EBITDA break-even for the first time since acquisition.
- MedTech business delivered a revenue of approximately ₹47 crore, reflecting strong growth momentum.
Investors can access the full transcript via the link provided in the official exchange filing. The document was signed by Tushar Shah, Vice President & Company Secretary.
What the Numbers Show
The release of the transcript provides granular insight into the drivers behind Shalby’s Q1 FY27 performance. While consolidated EBITDA margins contracted to 14.5% from 16% in Q1 FY26, the standalone hospital segment maintained robust profitability with an EBITDA margin of 18.4%. The improvement in hospital occupancy to 51% alongside stable ARPOB suggests volume-led growth is supporting top-line expansion, even as margin pressures persist due to new specialty deployments and TPA renewals. The achievement of EBITDA positivity at the Gurgaon unit marks a significant turnaround milestone for the international segment.
Historical Stock Returns for Shalby
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.81% | -5.15% | -10.56% | -0.86% | -38.16% | 0.0% |
How will the ongoing margin pressures from new specialty deployments and TPA renewals impact Shalby's EBITDA trajectory in Q2 FY27?
What specific operational strategies is Shalby employing to sustain the turnaround momentum at the Gurgaon unit beyond its initial EBITDA break-even?
Given the 11.6% revenue growth, what are the primary drivers expected to fuel the MedTech business's continued expansion in the coming quarters?
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
